Revolutionizing Metabolic and Neurological Health
The Power of the Gut-Brain Axis
Our lead program, BL-001, is a live biotherapeutic product reverse engineered to replicate the ketogenic diet’s clinical efficacy. BL-001 has demonstrated proof of mechanism and has been observed to be safe and tolerable, with Bloom planning Phase 2 clinical trials in both obesity and Dravet syndrome.
The IrisRx™ discovery platform powers Bloom’s pipeline by integrating cutting-edge science and a proprietary knowledgebase. This platform enables the development of novel, multi-pathway therapeutics through gut commensal microbes and synthetic biology, delivering innovative treatments with broad therapeutic potential.
Pioneering a New Class of Treatments
Bloom Science is redefining medicine by creating innovative therapies that harness the body’s natural metabolic and neurological pathways. Inspired by the therapeutic benefits of the ketogenic diet, Bloom’s approach targets multiple mechanisms simultaneously to provide safer, more effective solutions for obesity, Dravet syndrome, ALS, and other complex conditions.
Inspired by the therapeutic benefits of the ketogenic diet
Leadership
We are a team of passionate and committed scientists, data-geeks, advocates, and entrepreneurs developing first-in-class, breakthrough therapeutics that target metabolic health and the Gut-Brain Axis. Our goal is to transform the quality of life of patients and their families with unmet needs.
Partners
We are interested in collaborators who share our vision and goals, and whose capabilities complement our best-in-class drug discovery platform and development team.
Careers
At Bloom, we are seeking innovative, passionate, and motivated team players- committed to changing the way we treat disease through groundbreaking science. We have built a team with extensive scientific, business, clinical and leadership backgrounds.
News
Bloom Science to Participate in Keystone Symposia on Obesity Therapeutics and Microbiome Revolution Symposium
Bloom Science to Participate in Keystone Symposia on Obesity Therapeutics and Microbiome Revolution Symposium SAN DIEGO, Calif., January 23, 2026 - Bloom Science, Inc., a clinical-stage biotechnology company developing next-generation live biotherapeutic...
Bloom Science to Participate in J.P. Morgan Healthcare Conference and Sachs Neuroscience Innovation Forum
Bloom Science to Participate in J.P. Morgan Healthcare Conference and Sachs Neuroscience Innovation Forum SAN DIEGO, Calif., January 8, 2026 - Bloom Science, Inc., a clinical-stage biotechnology company developing next-generation live biotherapeutic...
Bloom Science Engages Epilepsy Community at American Epilepsy Society Meeting 2025
Bloom Science Engages Epilepsy Community at American Epilepsy Society Meeting 2025 SAN DIEGO, Calif., December 3, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological...
